Novo to show real-world Wegovy vs resmetirom data
Twelve abstracts head to The Liver Meeting, including a real-world comparison with resmetirom and four on investigational efruxifermin. Novo has a busy week lined up in Denver. The company says it’s bringing 12 new abstracts to The Liver Meeting, the American Association for the Study of Liver Disea
<p>Twelve abstracts head to The Liver Meeting, including a real-world comparison with resmetirom and four on investigational efruxifermin. Novo has a busy week lined up in Denver. The company says it’s bringing 12 new abstracts to The Liver Meeting, the American Association for the Study of Liver Disea</p>